166 related articles for article (PubMed ID: 36243044)
1. Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis.
Argemi J; Kedia K; Gritsenko MA; Clemente-Sanchez A; Asghar A; Herranz JM; Liu ZX; Atkinson SR; Smith RD; Norden-Krichmar TM; Day LZ; Stolz A; Tayek JA; Bataller R; Morgan TR; Jacobs JM;
Am J Pathol; 2022 Dec; 192(12):1658-1669. PubMed ID: 36243044
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.
Harris PS; Michel CR; Yun Y; McGinnis CD; Assiri MA; Ahmadi AR; Sun Z; Roede JR; Burchill MA; Orlicky DJ; McCullough RL; Fritz KS
Alcohol; 2022 Mar; 99():35-48. PubMed ID: 34923085
[TBL] [Abstract][Full Text] [Related]
3. Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
Taiwo M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell MC; Barton BA; Szabo G; Dasarathy S; ; Schaefer EA; Luther J; Day LZ; Ouyang X; Suyavaran A; Mehal WZ; Jacobs JM; Goodman RP; Rotroff DM; Nagy LE
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38573776
[TBL] [Abstract][Full Text] [Related]
4. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases.
Guldiken N; Argemi J; Gurbuz B; Atkinson SR; Oliverius M; Fila P; Hamesch K; Bruns T; Cabezas J; Lozano JJ; Mann J; Cao S; Mathurin P; Shah VH; Trautwein C; Thursz MR; Bataller R; Strnad P
BMC Med; 2021 Feb; 19(1):39. PubMed ID: 33593348
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated Hepatitis.
Fan X; McCullough RL; Huang E; Bellar A; Kim A; Poulsen KL; McClain CJ; Mitchell M; McCullough AJ; Radaeva S; Barton B; Szabo G; Dasarathy S; Rotroff DM; Nagy LE
Hepatology; 2021 Mar; 73(3):983-997. PubMed ID: 32557728
[TBL] [Abstract][Full Text] [Related]
6. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
[TBL] [Abstract][Full Text] [Related]
7. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
[TBL] [Abstract][Full Text] [Related]
8. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.
Gala KS; Vatsalya V
Cells; 2020 Feb; 9(3):. PubMed ID: 32106390
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis.
Yang Z; Zhang T; Kusumanchi P; Tang Q; Sun Z; Radaeva S; Peiffer B; Shah VH; Kamath P; Gores GJ; Sanyal A; Chalasani N; Jiang Y; Huda N; Ma J; Liangpunsakul S
Hepatology; 2021 Nov; 74(5):2436-2451. PubMed ID: 34096637
[TBL] [Abstract][Full Text] [Related]
10. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis.
Bou Saleh M; Louvet A; Ntandja-Wandji LC; Boleslawski E; Gnemmi V; Lassailly G; Truant S; Maggiotto F; Ningarhari M; Artru F; Anglo E; Sancho-Bru P; Corlu A; Argemi J; Dubois-Chevalier J; Dharancy S; Eeckhoute J; Bataller R; Mathurin P; Dubuquoy L
J Hepatol; 2021 Oct; 75(4):912-923. PubMed ID: 34129887
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.
Furuya S; Cichocki JA; Konganti K; Dreval K; Uehara T; Katou Y; Fukushima H; Kono H; Pogribny IP; Argemi J; Bataller R; Rusyn I
Toxicol Sci; 2019 Aug; 170(2):427-437. PubMed ID: 30517762
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis.
Taïeb J; Delarche C; Paradis V; Mathurin P; Grenier A; Crestani B; Dehoux M; Thabut D; Gougerot-Pocidalo MA; Poynard T; Chollet-Martin S
J Hepatol; 2002 Mar; 36(3):342-8. PubMed ID: 11867177
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.
Aguilar-Bravo B; Ariño S; Blaya D; Pose E; Martinez García de la Torre RA; Latasa MU; Martínez-Sánchez C; Zanatto L; Sererols-Viñas L; Cantallops-Vilà P; Affo S; Coll M; Thillen X; Dubuquoy L; Avila MA; Argemi J; Paz AL; Nevzorova YA; Cubero FJ; Bataller R; Lozano JJ; Ginès P; Mathurin P; Sancho-Bru P
J Hepatol; 2023 Sep; 79(3):728-740. PubMed ID: 37088308
[TBL] [Abstract][Full Text] [Related]
14. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients.
Khanova E; Wu R; Wang W; Yan R; Chen Y; French SW; Llorente C; Pan SQ; Yang Q; Li Y; Lazaro R; Ansong C; Smith RD; Bataller R; Morgan T; Schnabl B; Tsukamoto H
Hepatology; 2018 May; 67(5):1737-1753. PubMed ID: 29108122
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis.
Hardesty J; Day L; Warner J; Warner D; Gritsenko M; Asghar A; Stolz A; Morgan T; McClain C; Jacobs J; Kirpich I
Am J Pathol; 2022 Jul; 192(7):1066-1082. PubMed ID: 35490715
[TBL] [Abstract][Full Text] [Related]
16. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
17. Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
McLean Diaz P; Vannier A; Joshi AD; Mahle RE; Przybyszewski EM; Corey K; Chung RT; Luther J; Goodman RP; Schaefer EAK
Clin Transl Gastroenterol; 2023 Jun; 14(6):e00585. PubMed ID: 36972232
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis.
Blaya D; Rubio-Tomás T; Rodrigo-Torres D; Lozano J; Coll M; Argemi J; Altamirano J; Affò S; Morales-Ibanez O; Gratacós-Ginès J; Pose E; Tanguy M; Issoufaly T; Rautou PE; Bataller R; Caballería J; Sancho-Bru P
Hepatol Int; 2021 Aug; 15(4):1006-1017. PubMed ID: 33954832
[TBL] [Abstract][Full Text] [Related]
19. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
[TBL] [Abstract][Full Text] [Related]
20. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
